Skip to main content
PRECISION BIOSCIENCES INC logo

PRECISION BIOSCIENCES INC — Investor Relations & Filings

Ticker · DTIL ISIN · US74019P2074 LEI · 549300I5QGRS3BLHZH41 US Professional, scientific and technical activities
Open in API
Filings indexed 544 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country US United States of America
Listing US DTIL

About PRECISION BIOSCIENCES INC

https://precisionbiosciences.com/

Precision BioSciences is a clinical-stage gene editing company focused on developing therapeutic candidates using its proprietary ARCUS® genome editing platform. ARCUS is a novel technology that utilizes sequence-specific DNA-cutting enzymes, or nucleases, to perform targeted edits within living cells and tissues. The platform is designed to insert (knock-in), remove (knock-out), or repair DNA sequences. The company's primary application of this technology is the development of in vivo gene editing therapies aimed at overcoming and potentially curing rare genetic diseases and other hard-to-treat conditions.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Current Report on Form 8-K filed with the SEC (Regulation FD Disclosure and Other Events) announcing an investor webcast and furnishing a press release as an exhibit. It does not contain full financial statements or actual quarterly/annual results, nor is it a management presentation or earnings release. It is a general regulatory announcement, fitting the fallback category for miscellaneous SEC filings.
2026-05-27 English
8-K
Regulatory Filings Classification · 85% confidence The provided text is a U.S. SEC Form 8-K “Current Report” covering Items 5.02 (director/officer departures and elections), 5.03 (certificate of incorporation amendment), and 5.07 (submission of matters to a vote of security holders). It is not a full annual or quarterly report, an earnings release, nor a standalone proxy, but rather a multi-item regulatory filing. Therefore, it best fits the ‘Regulatory Filings (RNS)’ category.
2026-05-26 English
10-Q - PRECISION BIOSCIENCES INC (0001357874) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-05 English
8-K - PRECISION BIOSCIENCES INC (0001357874) (Filer)
Regulatory Filings Classification · 11% confidence The document is a Form 8-K current report filed with the U.S. SEC under the Exchange Act. It is a regulatory filing that furnishes a press release as an exhibit, rather than the full annual or interim report itself. Therefore it falls under the general Regulatory Filings category (RNS).
2026-05-05 English
ARS - PRECISION BIOSCIENCES INC (0001357874) (Filer)
Annual Report
2026-04-08 English
DEF 14A - PRECISION BIOSCIENCES INC (0001357874) (Filer)
Proxy Solicitation & Information Statement
2026-04-08 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.